How alcohol affects PrEP adherence in gay and bisexual men
The Impact of Alcohol on PrEP Adherence in Vulnerable Men
This study is looking at how drinking alcohol affects whether gay and bisexual men take their PrEP medication regularly, with the goal of finding ways to help them stick to their medication routine better.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10911903 on NIH RePORTER |
What this research studies
This research investigates the relationship between alcohol consumption and adherence to pre-exposure prophylaxis (PrEP) among gay and bisexual men (GBM). It aims to understand how alcohol use influences sexual behavior and the likelihood of taking PrEP consistently. The study will gather both qualitative and quantitative data, including personal narratives and real-time assessments, to explore patterns of alcohol use and its impact on daily medication adherence. By identifying these patterns, the research seeks to provide insights that could improve PrEP adherence in this vulnerable population.
Who could benefit from this research
Good fit: Ideal candidates for this research are gay and bisexual men who are at risk for HIV and currently using or considering PrEP.
Not a fit: Patients who do not identify as gay or bisexual or those who are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for enhancing PrEP adherence among gay and bisexual men, ultimately reducing the risk of HIV transmission.
How similar studies have performed: While there has been limited research specifically on alcohol's impact on PrEP adherence, studies have shown that substance use can negatively affect medication adherence in general, suggesting that this area is ripe for exploration.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Westmoreland, Drew Anne — University of Florida
- Study coordinator: Westmoreland, Drew Anne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.